Ipilimumab is a new drug treatment, monotherapy that is being investigated in patients with Advanced melanoma.In a report from the
Lancet a phase 2 clinical trial showed that the drug produced a dose dependant effect.Trials are still on going but the reaserch around this cancer is promising.
1 comment:
nice info
Post a Comment